Guidance on writing pathology reports for iMCD or ‘Castleman Disease-like changes’
Our expert panel has collaborated to provide guidance on the writing of pathology reports where you have identifed histopathological features consistent with the Castleman Disease spectrum. To access the guidance most appropriate to you, please select the scenario that applies.
Please note, the scenarios below assume you were provided with appropriate tissue. It is important to be aware that an excisional lymph node biopsy is recommended, and other biopsies - most commonly needle/core lymph node biopsies - can return false negatives.
OR
Abbreviations
iMCD, idiopathic Multicentric Castleman Disease.
Prescribing Information
Adverse events should be reported. (UK) Reporting forms and information can be found at
https://yellowcard.mhra.gov.uk/. (Ireland)
Healthcare professionals are requested to report suspected
adverse reactions to HPRA via their website https://www.hpra.ie/. Adverse events should also be reported to
Recordati UK Ltd by telephone: +44 (0)1491 414 333 or email: RRDpharmacovigilance@recordati.com.
